The medication addresses symptomatic domains linked to impaired blood flow and vascular capacity, providing targeted relief in two distinct clinical areas for specific patient populations. Its uses span both sexual and cardiopulmonary health.

The medication is commonly used to help manage symptoms across conditions characterized by temporary functional strain, primarily erectile dysfunction in adult men and pulmonary arterial hypertension (PAH) in both adults and children.

Quick Fact: Relief for Functional Strain The medication is relevant for managing symptoms that interfere with daily comfort.

Supportive Relief in Specific Conditions

This medication is relevant for managing symptoms that create noticeable physiological strain. It helps address symptom clusters associated with erectile dysfunction, which include the difficulty or inability to achieve or sustain an erection firm enough for sexual intercourse. In this context, the medication provides support that helps ease the symptomatic burden of functional impairment.

In the separate therapeutic domain of PAH, the Sildenafil molecule is applied to address symptoms linked to organ-specific functional stress, such as reduced exercise ability, fatigue, and shortness of breath. The medication assists with maintaining functional stability and helps maintain a sense of stability when symptoms are more noticeable. This supportive action helps ease the overall symptom load.

Regulatory References

1. NIH MedlinePlus overview of Sildenafil

The eligibility for Максигра (Sildenafil) is determined by specific population rules and contraindications mandated by regulatory labeling.

Populations for Whom Use is Contraindicated

Use is absolutely contraindicated in patients taking organic nitrates (in any form) or guanylate cyclase stimulators (e.g., Riociguat). The medicine is also prohibited for individuals with a history of Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION), severe hepatic impairment (Child-Pugh Class C), severe hypotension, or a recent history of stroke or myocardial infarction (within six months). Individuals with known hypersensitivity to sildenafil must not use the medicine.

Eligibility and Restrictions

Category	Regulatory Status	Status Detail
Age (ED Indication)	Allowed	Restricted to Adult Men (18 years and over). Not indicated for women.
Age (PAH Indication)	Allowed/Restricted	Indicated for adults and children ge 1 year; chronic use is not recommended in children due to safety warnings.
Organ Impairment	Restricted	Lower starting dose considered for severe renal impairment and mild-to-moderate hepatic impairment.
Specific Conditions	Caution/Not Recommended	Use requires caution in patients with conditions predisposing them to priapism (e.g., sickle cell disease) or anatomical penile deformities. Use is not recommended for patients with Pulmonary Veno-Occlusive Disease (PVOD).

Interactions with Other Medicines and Products

The interaction profile of Максигра (Sildenafil) is structured by two primary concerns documented in regulatory prescribing information: severe pharmacodynamic potentiation and altered pharmacokinetic clearance.

Formally Contraindicated Combinations

Co-administration of Sildenafil is prohibited with certain drug classes due to the risk of severe, additive hypotensive effects:

• Organic Nitrates or Nitric Oxide Donors: Use with any form of organic nitrate is strictly forbidden due to the potential for significant, life-threatening blood pressure drops.
• Guanylate Cyclase (GC) Stimulators: Sildenafil is contraindicated for co-administration with GC stimulators, such as Riociguat, due to potentiated systemic hypotension.

Exposure-Altering Interactions

Sildenafil is metabolized primarily by the CYP3A4 enzyme, leading to clinically significant interactions with medicines that affect this pathway:

• CYP3A4 Inhibitors: Potent inhibitors, including Ritonavir, Ketoconazole, and Erythromycin, reduce the clearance of Sildenafil, resulting in a marked increase in its systemic exposure (AUC and Cmax).
• CYP3A4 Inducers: Substances like Bosentan and Rifampin may increase Sildenafil clearance, potentially reducing its plasma levels.

Pharmacodynamic and Timing Constraints

Interactions that require mandated administration constraints include those with certain blood pressure-lowering agents:

• Alpha-Blockers: Co-administration may lead to symptomatic hypotension due to additive vasodilatory effects, requiring specific dose initiation protocols and patient stabilization as directed by regulatory labeling.
• Food and Products: Grapefruit juice is documented to modestly increase Sildenafil plasma levels by inhibiting CYP3A4 in the gut wall. Reduced clearance is also noted in patients with severe hepatic or severe renal impairment.

How Максигра Works

The mechanism of Максигра (sildenafil) is centered on modifying the chemical signals that regulate blood vessel tone, amplifying the physiological cascade initiated by stimulation.

Selective Enzyme Inhibition and Signal Amplification

Sildenafil functions as a selective competitive inhibitor of the enzyme Phosphodiesterase type 5 (PDE5), which is predominantly expressed in the smooth muscle lining of certain blood vessels. By blocking PDE5, the drug prevents the rapid degradation of the signaling molecule, cyclic Guanosine Monophosphate (cGMP). This preservation of cGMP levels increases the duration and magnitude of the downstream signal initiated by the release of Nitric Oxide (NO).

Conditional Vascular Tone Modulation

The prolonged presence of cGMP acts as a messenger that mediates the relaxation of vascular smooth muscle, resulting in vasodilation and altered local pressure dynamics. This mechanism is strictly stimulus-dependent, meaning sildenafil only potentiates the natural physiological response that begins with the release of NO, and does not initiate the change in vascular tone spontaneously. This conditional action modifies pressure dynamics within the specific tissue.

The active ingredient in Максигра, Sildenafil, has two distinct administration protocols for its approved uses: Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH). The route of administration is primarily oral, via film-coated tablets, although an intravenous (IV) injection is also approved for PAH patients temporarily unable to take the medication orally.

Official Administration Guidelines

Usage Pattern	Erectile Dysfunction (ED) Protocol	Pulmonary Arterial Hypertension (PAH) Protocol
Dose & Frequency	Starting dose is typically 50 mg as needed, not to exceed 100 mg once daily. Dosing occurs approximately one hour prior to activity.	Standard oral dose is 20 mg administered three times a day (TID), with doses separated by 4 to 8 hours. The IV dose is 10 mg TID.
Intake Condition	May be taken with or without food; however, a high-fat meal may delay the onset of effect. Sexual stimulation is required for therapeutic activity.	May be taken with or without food. For the oral suspension, reconstitution with water is required before use.
Population Adjustments	A lower starting dose of 25 mg should be considered for older adults (65 years and older) and those with severe hepatic or renal impairment.	Pediatric dosing for PAH is determined by body weight.

The mandatory TID schedule for PAH requires adherence to strict dosing intervals for chronic management. Conversely, the ED regimen is strictly as-needed (PRN), with a maximum of one dose every 24 hours. If a dose is missed during the PAH schedule, instructions advise taking it as soon as possible, unless it is near the time for the next scheduled dose.

Research evidence / Overview of studies for Максигра

Evidence for use in Erectile Dysfunction (ED)

Research exploring Sildenafil (the active ingredient in Максигра) was conducted primarily through multiple large, short-term randomized, placebo-controlled trials. These studies evaluated the experiences of a broad range of adult men and examined changes in patient-reported functional tools, such as the IIEF scale. Data show patterns related to measured scores and functional success rates in the Sildenafil groups, which was monitored alongside the outcomes for the placebo groups. The core efficacy trials often had limited follow-up durations.

Evidence for use in Pulmonary Arterial Hypertension (PAH)

Clinical evaluation for PAH was conducted using multinational, randomized, controlled trials. These studies focused on monitoring physiological strain and functional capacity. The key measurement used was the 6-Minute Walk Distance (6MWD), which was used to monitor outcomes reflecting activity level. Data show patterns related to measured changes in 6MWD scores in the Sildenafil groups.

Long-term studies and follow-up

While primary trials were short-term, researchers conducted follow-up through long-term open-label extension studies for periods up to one to three years. These studies monitored patterns of continued use, but there is limited information for long-term outcomes that extend beyond five years of observation.

Research in specific populations

Research examined special populations, including older adult men with ED and dedicated trials for children and adolescents with PAH. However, subsequent evidence indicates that long-term effects are not fully established in children, and the complexity of these data has led to differing regulatory conclusions.

Evidence Gaps and Areas of Uncertainty

Scientific literature acknowledges that long-term effects are not fully established for either indication. Additionally, comparative evidence is lacking regarding outcomes against newer therapies. Finally, the complex data observed in pediatric PAH studies means certainty remains low for long-term functional patterns in that specific population.

Key Studies & References

1. Sildenafil - StatPearls - NCBI Bookshelf
2. Sildenafil: MedlinePlus Drug Information

Common questions about Максигра (FAQ)

Q: What is Максигра and what is it used for?

Максигра contains the active substance sildenafil. Sildenafil belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.

It works by helping to relax the blood vessels in the penis, allowing blood to flow into the penis when sexually aroused. Максигра will only help you get an erection if you are sexually stimulated. It is a treatment for adult men with erectile dysfunction, sometimes called impotence.

Q: How does Максигра work to treat erectile dysfunction?

Максигра works by blocking a chemical called PDE5 in the body. PDE5 normally breaks down another substance called cyclic GMP (cGMP), which is responsible for relaxing the muscle cells in the blood vessel walls of the penis.

By blocking PDE5, Максигра allows cGMP levels to stay high. This causes the smooth muscle in the arteries of the penis to relax, increasing blood flow and leading to an erection when there is sexual arousal.

Q: What are the available strengths of Максигра?

Максигра is available in film-coated tablets with different strengths of sildenafil:

• 25 mg
• 50 mg
• 100 mg

The dosage prescribed by a doctor will depend on individual health status and response to the medication.

Q: How should I take Максигра?

• The usual starting dose is 50 mg.
• Take the tablet about one hour before you plan to have sexual activity.
• Swallow the tablet whole with water.
• It may be taken with or without food. However, taking it with a heavy meal may cause the medicine to take longer to start working.
• Do not take Максигра more than once a day.

Q: What are the common side effects of Максигра?

The most common side effects reported are usually mild to moderate and may include:

• Headache
• Flushing (redness and warmth of the face and upper body)
• Indigestion or heartburn
• Visual disturbances, such as blurred vision or a blue tinge to vision
• Nasal congestion (stuffy nose)
• Dizziness

Q: Can I take Максигра with other medicines?

It is crucial to tell your doctor or pharmacist about all other medicines you are taking, have recently taken, or might take, especially:

• Nitrates (often used for chest pain), as the combination can cause a dangerous drop in blood pressure.
• Guanylate cyclase stimulators (like riociguat) for pulmonary arterial hypertension.
• Alpha-blockers (used for high blood pressure or prostate issues), as this may lead to low blood pressure.
• Protease inhibitors (used for HIV treatment).
• Certain antifungals or antibiotics.

Taking Максигра with other medicines requires professional medical assessment to avoid serious interactions.

Q: Who should not take Максигра?

Максигра should not be used if you:

• Are allergic to sildenafil or any of the other ingredients.
• Take medicines called nitrates or nitric oxide donors (e.g., amyl nitrite, 'poppers').
• Have a severe heart or liver problem.
• Have recently had a stroke or a heart attack.
• Have certain rare inherited eye diseases (like retinitis pigmentosa).
• Have low blood pressure.
• Have ever had loss of vision due to non-arteritic anterior ischemic optic neuropathy (NAION), sometimes described as 'stroke of the eye'.

Storage and Disposal of Максигра (Sildenafil)

Detail	Regulatory Requirement
Storage Temperature	Store tablets at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C [FDA/EMA].
Protection	Keep the product in the original container and protect from moisture [SmPC].
Child Safety	Must be stored out of the reach of children [NIH/General Labeling].
Suspension Stability	Reconstituted oral suspension must be discarded 60 days after the date of mixing; the expiration date must be written on the bottle label [FDA Label].
Disposal	Any unused or expired medicine must be disposed of in accordance with local requirements [SmPC]. Do not flush down the toilet unless explicitly instructed by the label, as environmental release must be avoided [NIH/FDA].

Official regulatory documentation defines the specific temperature range to ensure drug stability and requires storage in the original, moisture-protected container. For the oral suspension, an in-use limit of 60 days after reconstitution is mandated. Disposal must follow explicit local guidelines, and the product must be kept inaccessible to children.